Skip to content

Aurinia Pharmaceuticals AUPH Change in Inventories

Change in Inventories at other companies

Rogers Corporation logo
Rogers CorporationROG
$3.4M+362%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$437K-30.1%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$4M+300%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$2.17M+8.9%
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
$18.25M+525%
LQD
Liquidia CorporationLQDA
$4.57M+312%

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.3B+78.5%
Enterprise value$2.34B+78.3%
P/E7.7×-24.6×
P/S7.7×+2.5×

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's change in inventories?
Aurinia Pharmaceuticals (AUPH) reported change in inventories of $720K in Q1 2026.
How has Aurinia Pharmaceuticals's change in inventories changed year-over-year?
Aurinia Pharmaceuticals's change in inventories decreased by 89.7% year-over-year, from $6.97M to $720K.
What is the long-term trend for Aurinia Pharmaceuticals's change in inventories?
Over 2 years (2021 to 2023), Aurinia Pharmaceuticals's change in inventories has grown at a 67.7% compound annual growth rate (CAGR), from $5.64M to $15.87M.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.